TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES | ||||||
| ||||||
Consolidated Statements of Cash Flows |
| For Three Months Ended September 30, | ||||
(In millions) |
| 2024 |
| 2023 | ||
Cash flows from operating activities |
|
|
|
|
|
|
Net income |
| $ | 1,362 |
| $ | 1,709 |
Adjustments to net income: |
|
|
|
|
|
|
Depreciation |
|
| 383 |
|
| 303 |
Amortization of capitalized software |
|
| 19 |
|
| 17 |
Stock compensation |
|
| 87 |
|
| 79 |
Deferred taxes |
|
| (33) |
|
| (99) |
Increase (decrease) from changes in: |
|
|
|
|
|
|
Accounts receivable |
|
| (151) |
|
| (20) |
Inventories |
|
| (190) |
|
| (179) |
Prepaid expenses and other current assets |
|
| (23) |
|
| 28 |
Accounts payable and accrued expenses |
|
| 13 |
|
| 27 |
Accrued compensation |
|
| 149 |
|
| 145 |
Income taxes payable |
|
| 155 |
|
| (7) |
Changes in funded status of retirement plans |
|
| (24) |
|
| 26 |
Other |
|
| (15) |
|
| (92) |
Cash flows from operating activities |
|
| 1,732 |
|
| 1,937 |
|
|
|
|
|
|
|
Cash flows from investing activities |
|
|
|
|
|
|
Capital expenditures |
|
| (1,316) |
|
| (1,495) |
Proceeds from asset sales |
|
| — |
|
| 1 |
Purchases of short-term investments |
|
| (1,845) |
|
| (3,080) |
Proceeds from short-term investments |
|
| 2,700 |
|
| 2,885 |
Other |
|
| (26) |
|
| (5) |
Cash flows from investing activities |
|
| (487) |
|
| (1,694) |
|
|
|
|
|
|
|
Cash flows from financing activities |
|
|
|
|
|
|
Dividends paid |
|
| (1,187) |
|
| (1,126) |
Stock repurchases |
|
| (318) |
|
| (46) |
Proceeds from common stock transactions |
|
| 117 |
|
| 68 |
Other |
|
| (8) |
|
| (12) |
Cash flows from financing activities |
|
| (1,396) |
|
| (1,116) |
|
|
|
|
|
|
|
Net change in cash and cash equivalents |
|
| (151) |
|
| (873) |
Cash and cash equivalents at beginning of period |
|
| 2,740 |
|
| 3,439 |
Cash and cash equivalents at end of period |
| $ | 2,589 |
| $ | 2,566 |
|
|
|
|
|
|
|
Supplemental cash flow information |
|
|
|
|
|
|
Investment tax credit (ITC) used to reduce income taxes payable |
| $ | 220 |
| $ | — |
Total cash benefit related to the U.S. CHIPS and Science Act |
| $ | 220 |
| $ | — |